Nano-X Imaging (NNOX) Stock Forecast, Price Target & Predictions
NNOX Stock Forecast
Nano-X Imaging stock forecast is as follows: an average price target of $18.00 (represents a 184.81% upside from NNOX’s last price of $6.32) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
NNOX Price Target
NNOX Analyst Ratings
Nano-X Imaging Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Apr 02, 2024 | Ross Osborn | Cantor Fitzgerald | $18.00 | $10.33 | 74.25% | 184.81% |
Nano-X Imaging Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 1 |
Avg Price Target | - | - | $18.00 |
Last Closing Price | $6.32 | $6.32 | $6.32 |
Upside/Downside | -100.00% | -100.00% | 184.81% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Apr 02, 2024 | Cantor Fitzgerald | Overweight | Overweight | Hold |
Jan 19, 2024 | Cantor Fitzgerald | Overweight | Overweight | Hold |
Sep 08, 2023 | Alliance Global Partners | - | Buy | Initialise |
Nano-X Imaging Financial Forecast
Nano-X Imaging Revenue Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.45M | $2.13M | $2.44M | $2.20M | $1.81M | $1.30M |
Avg Forecast | $41.48M | $28.34M | $20.20M | $14.16M | $9.35M | $8.08M | $7.22M | $5.85M | $4.69M | $3.91M | $3.93M | $4.42M | $2.82M | $2.90M | $3.15M | $2.90M | $2.65M | $2.81M | $2.35M | $2.38M | $750.00K |
High Forecast | $53.11M | $36.28M | $25.87M | $18.13M | $11.97M | $10.35M | $9.25M | $7.49M | $6.01M | $5.00M | $5.03M | $5.65M | $3.57M | $3.71M | $4.04M | $3.71M | $3.39M | $3.60M | $2.35M | $2.50M | $785.05K |
Low Forecast | $32.66M | $22.32M | $15.91M | $11.15M | $7.36M | $6.37M | $5.69M | $4.61M | $3.70M | $3.08M | $3.10M | $3.48M | $2.10M | $2.28M | $2.48M | $2.28M | $2.08M | $2.22M | $2.35M | $2.27M | $714.95K |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | - | - | 2 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.85% | 0.81% | 0.87% | 0.94% | 0.76% | 1.74% |
Nano-X Imaging EBITDA Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | - | - | 2 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-18.31M | $12.10M | $-15.05M | $-15.92M | $-19.08M | $-22.04M |
Avg Forecast | $-8.30M | $-5.67M | $-4.04M | $-2.83M | $-1.87M | $-1.62M | $-1.44M | $-1.17M | $-938.38K | $-781.62K | $-786.13K | $-883.00K | $-564.67K | $-580.00K | $-631.00K | $-579.00K | $-529.00K | $-563.00K | $-469.00K | $-477.00K | $-150.00K |
High Forecast | $-6.53M | $-4.46M | $-3.18M | $-2.23M | $-1.47M | $-1.27M | $-1.14M | $-921.29K | $-739.01K | $-615.55K | $-619.10K | $-695.39K | $-420.50K | $-456.77K | $-496.93K | $-455.98K | $-416.61K | $-443.38K | $-469.00K | $-454.71K | $-142.99K |
Low Forecast | $-10.62M | $-7.26M | $-5.17M | $-3.63M | $-2.39M | $-2.07M | $-1.85M | $-1.50M | $-1.20M | $-1.00M | $-1.01M | $-1.13M | $-714.84K | $-742.66K | $-807.97K | $-741.38K | $-677.36K | $-720.89K | $-469.00K | $-499.29K | $-157.01K |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 31.63% | -22.88% | 26.73% | 33.94% | 40.01% | 146.90% |
Nano-X Imaging Net Income Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | - | - | 2 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-11.76M | $-44.84M | $-19.13M | $-19.61M | $-21.67M | $-20.18M |
Avg Forecast | $3.76M | $-916.48K | $-3.89M | $-6.28M | $-8.24M | $-8.82M | $-9.29M | $-9.92M | $-12.45M | $-10.56M | $-12.53M | $-15.08M | $-17.59M | $-17.40M | $-15.37M | $-19.72M | $-24.94M | $-24.36M | $-14.67M | $-14.73M | $-19.06M |
High Forecast | $5.14M | $-663.34K | $-2.81M | $-4.55M | $-5.97M | $-6.39M | $-6.72M | $-7.18M | $-9.01M | $-9.11M | $-9.07M | $-10.92M | $-14.08M | $-12.60M | $-11.13M | $-14.27M | $-18.05M | $-17.63M | $-14.67M | $-13.83M | $-17.90M |
Low Forecast | $2.72M | $-1.25M | $-5.30M | $-8.57M | $-11.25M | $-12.04M | $-12.67M | $-13.53M | $-16.99M | $-12.02M | $-17.09M | $-20.58M | $-22.29M | $-23.75M | $-20.98M | $-26.91M | $-34.04M | $-33.24M | $-14.67M | $-15.62M | $-20.22M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.60% | 1.80% | 0.79% | 1.34% | 1.47% | 1.06% |
Nano-X Imaging SG&A Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | - | - | 2 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $8.96M | $9.68M | $11.33M | $12.23M | $12.39M | $12.86M |
Avg Forecast | $349.75M | $238.95M | $170.34M | $119.42M | $78.83M | $68.16M | $60.89M | $49.32M | $39.56M | $32.95M | $33.14M | $37.23M | $23.81M | $24.45M | $26.60M | $24.41M | $22.30M | $23.74M | $19.77M | $20.11M | $6.32M |
High Forecast | $447.84M | $305.96M | $218.11M | $152.91M | $100.93M | $87.28M | $77.97M | $63.16M | $50.66M | $42.20M | $42.44M | $47.67M | $30.14M | $31.31M | $34.07M | $31.26M | $28.56M | $30.39M | $19.77M | $21.05M | $6.62M |
Low Forecast | $275.44M | $188.18M | $134.15M | $94.05M | $62.08M | $53.68M | $47.95M | $38.84M | $31.16M | $25.95M | $26.10M | $29.32M | $17.73M | $19.26M | $20.95M | $19.23M | $17.57M | $18.69M | $19.77M | $19.17M | $6.03M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.37% | 0.43% | 0.48% | 0.62% | 0.62% | 2.03% |
Nano-X Imaging EPS Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | - | - | 2 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.21 | $-0.86 | $-0.37 | $-0.38 | $-0.42 | $-0.42 |
Avg Forecast | $0.06 | $-0.02 | $-0.07 | $-0.11 | $-0.14 | $-0.15 | $-0.16 | $-0.17 | $-0.21 | $-0.18 | $-0.22 | $-0.26 | $-0.30 | $-0.30 | $-0.27 | $-0.34 | $-0.43 | $-0.42 | $-0.25 | $-0.26 | $-0.33 |
High Forecast | $0.09 | $-0.01 | $-0.05 | $-0.08 | $-0.10 | $-0.11 | $-0.12 | $-0.12 | $-0.16 | $-0.16 | $-0.16 | $-0.19 | $-0.24 | $-0.22 | $-0.19 | $-0.25 | $-0.31 | $-0.30 | $-0.25 | $-0.24 | $-0.31 |
Low Forecast | $0.05 | $-0.02 | $-0.09 | $-0.15 | $-0.19 | $-0.21 | $-0.22 | $-0.23 | $-0.29 | $-0.21 | $-0.29 | $-0.35 | $-0.38 | $-0.41 | $-0.36 | $-0.46 | $-0.59 | $-0.57 | $-0.25 | $-0.27 | $-0.35 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.62% | 2.00% | 0.88% | 1.50% | 1.65% | 1.27% |
Nano-X Imaging Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
NVCR | NovoCure | $18.57 | $67.92 | 265.75% | Hold |
NNOX | Nano-X Imaging | $6.32 | $18.00 | 184.81% | Buy |
IART | Integra LifeSciences | $17.47 | $43.25 | 147.57% | Sell |
ALGN | Align | $243.73 | $554.38 | 127.46% | Buy |
PACB | Pacific Biosciences of California | $1.81 | $3.00 | 65.75% | Buy |
HYPR | Hyperfine | $1.04 | $1.60 | 53.85% | Buy |
EW | Edwards Lifesciences | $68.52 | $97.09 | 41.70% | Buy |
MDT | Medtronic | $90.00 | $106.77 | 18.63% | Hold |
DXCM | DexCom | $69.51 | $81.86 | 17.77% | Buy |
ABT | Abbott Laboratories | $116.40 | $129.50 | 11.25% | Buy |
SYK | Stryker | $370.25 | $305.00 | -17.62% | Buy |
SWAV | ShockWave Medical | $334.75 | $258.17 | -22.88% | Hold |
NNOX Forecast FAQ
Is Nano-X Imaging a good buy?
Yes, according to 2 Wall Street analysts, Nano-X Imaging (NNOX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 100.00% of NNOX's total ratings.
What is NNOX's price target?
Nano-X Imaging (NNOX) average price target is $18 with a range of $18 to $18, implying a 184.81% from its last price of $6.32. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Nano-X Imaging stock go up soon?
According to Wall Street analysts' prediction for NNOX stock, the company can go up by 184.81% (from the last price of $6.32 to the average price target of $18), up by 184.81% based on the highest stock price target, and up by 184.81% based on the lowest stock price target.
Can Nano-X Imaging stock reach $9?
NNOX's average twelve months analyst stock price target of $18 supports the claim that Nano-X Imaging can reach $9 in the near future.
What are Nano-X Imaging's analysts' financial forecasts?
Nano-X Imaging's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $30.5M (high $39.06M, low $24.02M), average EBITDA is $-6.1M (high $-4.804M, low $-7.811M), average net income is $-36.271M (high $-26.252M, low $-49.494M), average SG&A $257.2M (high $329.34M, low $202.56M), and average EPS is $-0.625 (high $-0.453, low $-0.853). NNOX's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $104.18M (high $133.39M, low $82.04M), average EBITDA is $-20.835M (high $-16.408M, low $-26.678M), average net income is $-7.32M (high $-2.886M, low $-12.402M), average SG&A $878.46M (high $1.12B, low $691.82M), and average EPS is $-0.126 (high $-0.0498, low $-0.214).
Did the NNOX's actual financial results beat the analysts' financial forecasts?
Based on Nano-X Imaging's last annual report (Dec 2022), the company's revenue was $8.58M, which missed the average analysts forecast of $10.19M by -15.82%. Apple's EBITDA was $-37.194M, beating the average prediction of $-2.038M by 1725.03%. The company's net income was $-105M, beating the average estimation of $-78.701M by 33.73%. Apple's SG&A was $45.63M, missing the average forecast of $85.93M by -46.90%. Lastly, the company's EPS was $-2.01, beating the average prediction of $-1.358 by 47.98%. In terms of the last quarterly report (Mar 2023), Nano-X Imaging's revenue was $2.45M, missing the average analysts' forecast of $2.9M by -15.47%. The company's EBITDA was $-18.312M, beating the average prediction of $-579K by 3062.70%. Nano-X Imaging's net income was $-11.761M, missing the average estimation of $-19.722M by -40.37%. The company's SG&A was $8.96M, missing the average forecast of $24.41M by -63.29%. Lastly, the company's EPS was $-0.21, missing the average prediction of $-0.34 by -38.24%